Upgrades:
American Express (NYSE:AXP) was upgraded by investment analysts at Edward Jones from a "hold" rating to a "buy" rating in a report issued on Monday, Briefing.com reports.
Several other equities analysts have also commented on the
company. Oppenheimer reaffirmed an "outperform" rating and issued a
$200.00 price target on shares of American Express in a research note on
Wednesday, March 23rd. Robert W. Baird reaffirmed a "neutral" rating
and issued a $175.00 price target on shares of American Express in a research
note on Tuesday, April 26th. StockNews.com initiated coverage on American
Express in a research note on Thursday, March 31st. They issued a
"hold" rating on the stock. Citigroup upped their price target on
American Express from $187.00 to $190.00 and gave the company a
"neutral" rating in a research note on Tuesday, April 26th. Finally,
Morgan Stanley boosted their price objective on American Express from $218.00
to $223.00 and gave the company an "overweight" rating in a report on
Monday, March 28th. One investment analyst has rated the stock with a sell
rating, fourteen have issued a hold rating and eight have issued a buy rating
to the stock. According to MarketBeat.com, American Express presently has a
consensus rating of "Hold" and a consensus target price of $192.26. Read
more …
ResMed (NYSE:RMD) was upgraded by research analysts at Royal Bank of Canada from a "sector perform" rating to an "outperform" rating in a report issued on Monday, The Fly reports.
A number of other equities research analysts have also
commented on RMD. Wolfe Research assumed coverage on ResMed in a research
report on Tuesday, April 5th. They issued an "outperform" rating and
a $280.00 target price on the stock. StockNews.com downgraded ResMed from a
"buy" rating to a "hold" rating in a report on Monday, May
2nd. Six analysts have rated the stock with a hold rating and nine have issued
a buy rating to the stock. According to MarketBeat.com, the company presently
has an average rating of "Buy" and an average target price of
$267.11.
Shares of RMD opened at $208.31 on Monday. The company has a
market cap of $30.47 billion, a PE ratio of 39.23, a P/E/G ratio of 2.31 and a
beta of 0.45. The business has a fifty day moving average of $217.93 and a 200
day moving average of $237.23. ResMed has a 52-week low of $189.40 and a
52-week high of $301.34. The company has a quick ratio of 1.56, a current ratio
of 2.55 and a debt-to-equity ratio of 0.20. Read
more …
AmerisourceBergen (NYSE:ABC) was upgraded by research analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "buy" rating in a report released on Tuesday, Briefing.com reports. The brokerage presently has a $178.00 target price on the stock, up from their previous target price of $167.00. Deutsche Bank Aktiengesellschaft's target price would indicate a potential upside of 21.18% from the stock's current price.
Several other equities analysts have also weighed in on the
company. Morgan Stanley reduced their price objective on AmerisourceBergen from
$178.00 to $175.00 and set an "equal weight" rating on the stock in a
research note on Friday, May 27th. Evercore ISI reduced their price objective
on AmerisourceBergen to $165.00 in a research note on Friday. Barclays raised
AmerisourceBergen from an "equal weight" rating to an
"overweight" rating and lifted their price objective for the company
from $175.00 to $182.00 in a research note on Thursday, May 26th. Argus lifted
their price objective on AmerisourceBergen from $140.00 to $160.00 in a
research note on Monday, March 14th. Finally, Mizuho raised their target price
on AmerisourceBergen from $139.00 to $162.00 in a report on Thursday, May 5th.
Three research analysts have rated the stock with a hold rating, four have
given a buy rating and one has issued a strong buy rating to the company.
According to MarketBeat, the company currently has an average rating of
"Buy" and a consensus price target of $169.25. Read
more …
McKesson (NYSE:MCK) was upgraded by investment analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "buy" rating in a note issued to investors on Tuesday, The Fly reports.
Several other brokerages have also recently weighed in on
MCK. Robert W. Baird raised their price target on shares of McKesson from
$352.00 to $380.00 in a research report on Friday, May 6th. Credit Suisse Group
raised their price target on shares of McKesson from $333.00 to $377.00 in a research
report on Wednesday, May 11th. Mizuho raised their price target on shares of
McKesson from $280.00 to $331.00 in a research report on Monday, May 9th.
StockNews.com initiated coverage on shares of McKesson in a research report on
Thursday, March 31st. They issued a "strong-buy" rating on the stock.
Finally, UBS Group raised their price target on shares of McKesson to $380.00
and gave the company a "hold" rating in a research report on
Thursday, May 19th. Two investment analysts have rated the stock with a hold
rating, ten have given a buy rating and one has issued a strong buy rating to
the company's stock. According to MarketBeat, McKesson currently has an average
rating of "Buy" and a consensus target price of $326.00. Read
more …